跳至主要内容
临床试验/ITMCTR2100005164
ITMCTR2100005164已完成未知

Drug-drug interaction between Zuojin pill and venlafaxine based on CYP2D6 activity

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
21 至 26(—)
性别
Male

入选标准

  • 1. Aged 19 to 45 years;
  • 2. The body weight is greater than 50kg, and the body mass index [weight kg/ (height m) 2] is between 19 and 24;
  • 3. Good health condition(no significant clinical symptoms or clinically significant abnormal laboratory results).

排除标准

  • 1. Allergic physique, with a history of drug or food allergy;
  • 2. Heart, liver, kidney disease or acute or chronic digestive tract disease, angle-closure glaucoma, epilepsy, thyroid disease, blood disease.Or other acute or chronic diseases that may affect drug absorption and metabolism;
  • 3. Positive hepatitis B surface antigen;
  • 4. Drug abusers and tobacco and alcohol abusers;
  • 5. Drinking alcohol within 36 hours before the test;
  • 6. Blood loss or blood donation of more than 200 ml within 3 months before the test;
  • 7. Taking other drugs within 2 weeks before the test;
  • 8. According to the judgment of the researcher, those who are less likely to be included (such as weak body, etc.).

研究者

发起方
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

相似试验